CLSK slides around 7.5% as technical indicators point to ongoing selling and oversold conditions

CLSK slides around 7.5% as technical indicators point to ongoing selling and oversold conditions
Cleanspark slides 7.58% today

CleanSpark, Inc. (CLSK) fell 7.58% on sustained selling pressure, as downward momentum and deeply oversold signals defined today's move. The decline is supported by the stock holding well below its major moving averages, with resistance higher and the broader trend remaining bearish.

CLSK price prediction
24H -0.98%
$9.14
48H -2.6%
$8.99
7D -2.82%
$8.97
1M -19.93%
$7.39
3M -22.54%
$7.15
6M -41.93%
$5.36
12M -40.85%
$5.46
Current price: $9.23 -0.9300 9.16%
Closed 10/14
Daily range 8.93 Arrow from to Icon 9.79
Weekly range 8.93 Arrow from to Icon 11.28
Loading...

Highlights

  • Shares of CleanSpark trade below key moving averages, with the longer-term trend remaining bearish and the stock at $9.38.
  • Momentum indicators show persistent weakness, with oversold conditions and sellers dominating after a 7.58% daily drop.
  • The expected price range for the next five days is $8.59 to $10.41, with a high probability of further downside.
Anton Kharitonov, expert at Traders Union, sees CleanSpark suffering from clear technical weakness across all major timeframes. The stock remains pinned well below every relevant moving average, with the RSI and Stochastic indicating deeply oversold momentum. No news supports or justifies the move, underscoring a sentiment vacuum and an absence of positive catalysts. With negative flow across all technical indicators, he believes downside risk prevails and the bullish case is unconvincing. "Until the price can reclaim the $10.41 resistance, I see little incentive for investors to take new risks here."
Viktoras Karapetjanc, expert at Traders Union, remains constructive on CleanSpark’s setup despite current pressure. He highlights the oversold state on momentum readings as an opportunity for reactive buyers. No negative news catalysts surfaced, suggesting the selloff may be overdone from a fundamental angle. The analyst believes the volatility profile could spark short-term mean reversion and setups around $8.59 support. "With sentiment stretched and no fundamental deterioration, any rebound above $10.41 unlocks new growth opportunities for active participants."
Sholanke Dele, market strategist, points to persistent selling pressure and deteriorating sentiment around CleanSpark. The stock’s inability to stabilize, even without fresh news, exposes how fragile confidence has become. He notes that broad trends and intraday action both lean bearish, with no macro or institutional catalysts visible. "Given the lack of support and momentum, I see little reason to expect a sustained recovery in the near term."
CleanSpark asset chart
CleanSpark price dynamics. Source: TradingView.

Technical breakdown extends with resistance rising and momentum weakening

CleanSpark is trading well below its 20-day, 50-day, and 200-day simple moving averages ($12.80, $12.55, and $12.56 respectively), signaling sustained downward pressure across short-, medium-, and long-term trends. The nearest price pivot is resistance near $9.69, with support at $8.59, and the longer-term trend remains bearish. Momentum indicators also point to ongoing weakness, with a bearish MACD, neutral ADX, RSI deep in sell territory at 29.91, Stochastic RSI at 0, and an oversold CCI. Bull/Bear Power (BBP) is negative and the Awesome Oscillator (AO) confirms continued selling, with intraday volatility at 5.47% and the stock near session lows.

Earlier, analysts noted that CleanSpark faced persistent bearish momentum and elevated downside risk following sustained selling pressure and technical weakness. The current article reaffirms this negative outlook with fresh evidence of deeply oversold signals and reinforces the view that a break below $8.59 could signal renewed downside risk in the coming sessions.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.